Picture of Wakamoto Pharmaceutical logo

4512 — Wakamoto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Table: Wakamoto Pharm - 6-MTH parent results

Nov 2 (Reuters)-  
             Wakamoto Pharmaceutical Co Ltd  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2017        Sep 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             5.42                5.49             10.93     
                 (-1.2 pct)          (-0.1 pct)       (+0.9 pct)   
  Operating     loss 105 mln         loss 59 mln        100 mln    
                                                      (+14.5 pct)  
  Recurring     loss 108 mln         loss 51 mln        80 mln     
                                                      (-22.3 pct)  
  Net            loss 84 mln         loss 33 mln        30 mln     
                                                      (-68.3 pct)  
  EPS           loss 2.43 yen       loss 0.97 yen      0.86 yen    
  Ann Div                             3.00 yen                     
  -Q2 div            NIL                 NIL                       
  -Q4 div                             3.00 yen                     
   
  NOTE - Wakamoto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Wakamoto Pharmaceutical

See all news